Gennady Bratslavsky, MD

WEB RESOURCES

ASSOCIATIONS / MEMBERSHIPS

RESEARCH ABSTRACT

Bibliography

Peer- reviewed publications

1. Figge J, del Rosario AD, Gerasimov G, Dedov I, Bronstein M, Troshina K, Alexandrova G, Kallakury BV, Bui HX, Bratslavsky G, . Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol 1994;61:203-11.
2. Jennings T, Bratslavsky G, Gerasimov G, Troshina K, Bronstein M, Dedov I, Alexandrova G, Figge J. Nuclear accumulation of MDM2 protein in well-differentiated papillary thyroid carcinomas. Exp Mol Pathol 1995;62:199-206.
3. Bratslavsky G, Whitbeck C, Horan P, Levin RM. Effects of in vivo ischemia on contractile responses of rabbit bladder to field stimulation, carbachol, ATP and KCl. Pharmacology 1999;59:221-6.
4. Herman C, Bratslavsky G, Miller R. Sneddon's Syndrome in a 59-year old caucasian male with hyperhomocysteinemia. J Amer Ger Soc 1999;47:33-4.
5. Bratslavsky G, Kogan B, Levin RM. Urethra is more sensitive to ischemia than bladder: evidence from an in vitro rat study. J Urol 2001;165:2086-90.
6. Matsumoto S, Chichester P, Bratslavsky G, Kogan BA, Levin RM. The functional and structural response to distention of the rabbit whole bladder in vitro. J Urol 2002;168:2677-81.
7. Bratslavsky G, Kogan BA, Matsumoto S, Aslan AR, Levin RM. Reperfusion injury of the rat bladder is worse than ischemia alone. J Urol 2003;170:2086-90.
8. Bratslavsky G, Moran ME. Current trends in ureteroscopy. Urol Clin North Am 2004;31:181-7, xi.
9. Bratslavsky G, Feustel PJ, Aslan AR, Kogan BA. Recurrence risk in infants with urinary tract infections and a negative radiographic evaluation. J Urol 2004;172:1610-3.
10. Diaz-Parker C, Bratslavsky G. Urethritis, Epididymitis, and Prostatitis: Evaluation and Treatment. Clinician Review 2005;15:40-5.
11. Giorgi LJ, Jr., Bratslavsky G, Kogan BA. Febrile urinary tract infections in infants: renal ultrasound remains necessary. J Urol 2005;173:568-70.
12. Bratslavsky G, Sudarshan S, Neckers L, Linehan WM. Pseudohypoxic Pathways in Renal Cell Carcinoma. Clin Cancer Res 2007;13:4667-71.
13. Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, Pinto PA. Salvage Partial Nephrectomy for Hereditary Renal Cancer: Feasibility and Outcomes. J Urol 2007;179:67-70.
14. Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M, Choyke P, Linehan WM, Greene MH. A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report. BMC Journal of Medical Case Reports 2007;1:9.
15. Bratslavsky G, Fisher HAG, Kaufman RPJ, Voskoboynik D, Nazeer T, Mian BM. PSA-related markers in the detection of prostate cancer and high-grade disease in the contemporary era with extended biopsy. Urol Oncol 2008;26:166-70.
16. Eisenhofer G, Huynh TT, Elkahloun A, Morris JC, Bratslavsky G, Linehan WM, Zhuang Z, Balgley BM, Lee CS, Mannelli M, Lenders JW, Bornstein SR, Pacak K. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma. Am J Physiol Endocrinol Metab 2008;295:E1223-E1233.
17. Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G. Feasibility and outcomes of repeat partial nephrectomy. J Urol 2008;180:89-93.
18. Korde LA, Premkumar A, Mueller C, Rosenberg P, Soho C, Bratslavsky G, Greene MH. Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer 2008;99:1748-53.
19. Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, Pinto PA. Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis. J Urol 2008;180:2353-6.
20. Signoretti S, Bratslavsky G, Waldman FM, Reuter VE, Haaga J, Merino M, Thomas GV, Pins MR, Libermann T, Gillespie J, Tomaszewski JE, Compton CC, Hruszkewycz A, Linehan WM, Atkins MB. Tissue-based research in kidney cancer: current challenges and future directions. Clin Cancer Res 2008;14:3699-705.
21. Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G. Initial experience with robot assisted partial nephrectomy for multiple renal masses. J Urol 2009;182:1280-6.
22. Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G. Partial nephrectomy after previous radio frequency ablation: the national cancer institute experience. J Urol 2009;182:2158-63.
23. Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro DP, Neckers L, Schmidt LS, Srinivasan R. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 2009;115:2252-61.
24. Rosner I, Bratslavsky G, Pinto PA, Linehan WM. The clinical implications of the genetics of renal cell carcinoma. Urol Oncol 2009;27:131-6.
25. Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM, Bratslavsky G. Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma in Patients With von Hippel-Lindau Syndrome After at Least 5 Years of Followup. J Urol 2010;184:1855-9.
26. Bratslavsky G, Linehan WM. Long-term management of bilateral, multifocal, recurrent renal carcinoma. Nat Rev Urol 2010;7:267-75.
27. Tsivian M, Moreira DM, Caso JR, Mouraviev V, Madden JF, Bratslavsky G, Robertson CN, Albala DM, Polascik TJ. Predicting occult multifocality of renal cell carcinoma. Eur Urol 2010;58:118-26.
28. Bratslavsky G, Kirkali Z. The changing face of renal-cell carcinoma. J Endourol 2010;24:753-7.
29. Greene MH, Kratz CP, Mai PL, Mueller C, Peters JA, Bratslavsky G, Ling A, Choyke PM, Premkumar A, Bracci J, Watkins RJ, McMaster ML, Korde LA. Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer 2010;17:R109-R121.
30. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G. Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol 2010;184:59-63.
31. Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G. Partial adrenalectomy: underused first line therapy for small adrenal tumors. J Urol 2010;184:18-25.
32. Lenders JW, Pacak K, Huynh TT, Sharabi Y, Mannelli M, Bratslavsky G, Goldstein DS, Bornstein SR, Eisenhofer G. Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma. J Clin Endocrinol Metab 2010;95:238-45.
33. Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R. Molecular diagnosis and therapy of kidney cancer. Annu Rev Med 2010;61:329-43.
34. Liu NW, Khurana K, Sudarshan S, Pinto PA, Linehan WM, Bratslavsky G. Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol 2010;183:1719-24.
35. Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G. Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas. BJU Int 2010. Aug 19. [Epub ahead of print].
36. Singer EA, Bratslavsky G, Linehan WM, Srinivasan R. Targeted therapies for non-clear renal cell carcinoma. Target Oncol 2010.
37. Singer EA, Bratslavsky G. Management of locally recurrent kidney cancer. Curr Urol Rep 2010;11:15-21.
38. Sorbellini M, Bratslavsky G. Renal cell carcinoma and prognostic factors predictive of survival. Ann Surg Oncol 2010;17:362-3.
39. Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet 2010;196:45-55.
40. Noureddin M, Kleiner DE, Gharib AM, Bratslavsky G, Heller T. To resect or not to resect? That is the question. Gut. 2010 Sep 24. [Epub ahead of print]
41. Eisenhofer G, Pacak K, Huynh TT, Qin N, Bratslavsky G, Linehan WM, Mannelli M, Friberg P, Grebe S, Timmers HJ, Bornstein SR, Lenders JW. Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma. Endocr Relat Cancer. 2010 Nov 4. [Epub ahead of print]
42. Boris R, Gupta GN, Linehan WM, Pinto PA, Bratslavsky G. Robot Assisted Laparoscopic Partial Adrenalectomy: Initial Experience. Urology. 2010 Nov 29. [Epub ahead of print]
43. Singer EA, Bratslavsky G, Middelton L, Srinivasan R, Linehan WM. Impact of Genetics on the Diagnosis and Treatment of Renal Cancer. Curr Urol Rep. 2010 Dec 3. [Epub ahead of print]
44. Eisenhofer G, Timmers HJ, Lenders JWM, Bornstein SR, Tiebel O, Mannelli M, King KS, Vocke C, Linehan WM, Bratslavsky G, Pacak K. Age at Diagnosis of Pheochromocytoma Differs according to Catecholamine Phenotype and Tumor Location. J Clin Endocrinol Metab. 2010 Dec 8. [Epub ahead of print]
45. Bratslavsky G. and Boris R. Emerging strategies in nephron sparing surgery in patients with localized and recurrent renal cell carcinoma. Malign Tumours 2010; 1:5-14.
46. Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G. Renal Cell Carcinoma with Metastases to Gallbladder: Four Cases from the National Cancer Institute (NCI) and Review of the Literature. Urol Oncol. 2011 Jan 28. [Epub ahead of print].
47. Eisenhofer G, Lenders JWM, Timmers HJ, Mannelli M, Grebe SK, Hofbauer LC, Bornstein SR, Tiebel O, Adams K, Bratslavsky G, Linehan WM, Pacak K. Measurements of Plasma Methoxytyramine, Normetanephrine and Metanephrine as Discriminators of Different Hereditary forms of Pheochromocytoma. Clin Chem 2011 Jan 24. [Epub ahead of print]
48. Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G. Feasibility and Outcomes of Partial Nephrectomy for Resection of at Least 20 Tumors in a Single Renal Unit. J Urol. 2011 Jan;185(1):49-53.
49. Kratz CP, Bratslavsky G, Shi J. The clinical utility of testicular cancer risk loci. Genome Med. 2011 Jan 21;3(1):1. [Epub ahead of print]
50. Rastinehad AR, Baccala AA Jr, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA. D'Amico Risk Stratification Correlates With Degree of Suspicion of Prostate Cancer on Multiparametric Magnetic Resonance Imaging. J Urol. 2011 Jan 14. [Epub ahead of print]
51. Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G. The mpact of germline BHD mutation on histologic concordance and clinical management of patients with bilateral renal masses and known unilateral oncocytoma. J Urol 2011; Accepted for publication.
52. Kratz CP, Shi J Bratslavsky G, Greene MH. A stratified genetic risk assessment for testicular cancer. Int J Androl. 2011. Accepted for publication.
53. Gupta GN, Boris RS, Chung P, Linehan WM, Pinto PA, Bratslavsky G. Robot-Assisted Laparoscopic Partial Nephrectomy for Tumors Greater than 4 cm and High Nephrometry Score: Feasibility, Renal Functional and Oncological Outcomes with Minimum 1 Year Follow-up. Urol Oncol. 2011 Feb 1. [Epub ahead of print]
54. Robot-assisted Laparoscopic Partial Adrenalectomy for Pheochromocytoma: The National Cancer Institute Technique. Accepted for publication in European Urology. 2011.
55. Baris Turkbey, M.D.;Haresh Mani, M.D.;Vijay Shah, Ph.D.;Ardeshir R. Rastinehad, D.O.;Marcelino Bernardo, B.S.; Thomas Pohida, M.S.;Yuxi pang, Ph.D.;Dagane Daar, R.T.;Compton Benjamin, M.D.; Ph.D.;Yolanda L. McKinney, R.N.;Hari Trivedi;Celene Chua, R.N.;Gennady Bratslavsky, M.D.;Joanna H. Shih, Ph.D.;William M. Linehan, M.D.;Maria J. Merino, M.D.;Peter L. Choyke, M.D.;Peter A. Pinto, M.D. Multiparametric 3T Prostate MR Imaging to Detect Cancer: Histopathologic Correlation Using Prostatectomy Specimens Processed in Customized MRI-Based Molds.
56. Ardeshir Rastinehad*, Jochen Kruecker, Compton Benjamin, Paul Chung, Baris Turkbey, Sheng Xu, Julia Locklin, Stacey Gates, Carey Buckner, Marston Linehan, Gennady Bratslavsky, Neil Glossop, Peter Choyke, Bradford Wood, Peter Pinto: MRI/US Fushion Prostate Biopsies: Cancer Detection Rates, Atract #846, AUA Annual Meeting, May 14-19, 2011 Meeting Program, p103.

Book Chapters and Invited Editorials

1. Bratslavsky G, Fisher HAG. Bladder Cancer Update. Urology Highlights 2003-2004; Health Press. Oxford.
2. Bratslavsky G, Rosner I, Linehan WM. Von Hippel-Lindau Disease. In: Gomella L, editor. 5 Minute Urology Consult. Submitted ed. Wolterkluwer/Lippincott Williams & Wilkins; 2009.
3. Linehan W, Dhanani N, Vocke C, Bratslavsky G. Molecular Genetics in Inherited Renal Cell Carcinoma: Identification of Targets in the Hereditary Syndromes. In: Bukowski RM, Figlin RA, Motzer R, editors. Renal Cancer : Molecular Targets and Clinical Applications. 2nd, XVII ed. Humana Press; 2009.
4. Proano JM, Bratslavsky G. Addison's Disease. In: Gomella L, editor. 5 Minute Urology Consult. 2nd ed. Wolterkluwer/Lippincott Williams & Wilkins; 2009.
5. Beck A, Wood B, Bratslavsky G. Ablation of small renal masses. In: Vogelzang, Scardino, Zelefsky, Linehan, editors. Comprehensive textbook of genitourinary oncology. 4th ed. 2010.
6. Bratslavsky G, Pinto P, Linehan W. Management of hereditary renal cell carcinoma. In: Vogelzang, Scardino, Zelefsky, Linehan, editors. Comprehensive textbook of genitourinary oncology. 4th ed. 2010.
7. Fonte J, Breza J, Linehan W, Bratslavsky G, Pacak K. Diagnosis and management of pheochromocytoma. In: Vogelzang, Scardino, Zelefsky, Linehan, editors. Comprehensive textbook of genitourinary oncology. 4th ed. 2010.
8. Pinto PA, Bratslavsky G. Robotic-assisted partial nephrectomy. In: Vogelzang, Scardino, Zelefsky, Linehan, editors. Comprehensive textbook of genitourinary oncology. 4th ed. 2010.
9. Singer EA, Srinivasan R, Bratslavsky G. Editorial Comment. J Urol. 2010 Nov 11. [Epub ahead of print].
10. Lane BR, Fergany AF, Linehan WM, Bratslavsky G. Should preservable parenchyma, and not tumor size, be the main determinant of the feasibility of partial nephrectomy? Urology 2010;76:608-9.
11. Bratslavsky G. and Boris R. Letter to the Editor regarding: "Functional and Oncologic Outcomes of Partial Adrenalectomy for Pheochromocytoma in Patients with von Hippel-Lindau Syndrome After at Least 5 Years of Follow Up". Scheduled for publication in the Journal of Urology in June 2011.
12. Shuck B, Pacak K, Linehan WM, Bratslavsky G. Editorial comment regarding: "The Predictive Factors of Malignant Pheochromocytomas: Analysis of 136 Patients". J Urol. 2011 May;185(5):1589-90.

HEALTHLINK ON AIR RADIO INTERVIEWS